Cargando…

Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study

PURPOSE: To assess whether extracorporeal treatment (ECTR) improves outcome of patients with metformin-associated lactic acidosis (MALA) and to evaluate the clinical applicability of the Extracorporeal Treatments in Poisoning Workgroup (EXTRIP) criteria for starting ECTR in metformin poisoning. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Berlo-van de Laar, Inge R.F., Vermeij, Cornelis G., van den Elsen-Hutten, Marjo, de Meijer, Arthur, Taxis, Katja, Jansman, Frank G.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Pharmacokinetics and Disposition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239820/ https://www.ncbi.nlm.nih.gov/pubmed/32170333 http://dx.doi.org/10.1007/s00228-020-02857-5

Ejemplares similares

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
por: Preijers, T., et al.
Publicado: (2021)

Evaluation of limited sampling strategies for tacrolimus
por: Op den Buijsch, Robert A. M., et al.
Publicado: (2007)

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer
por: Willemsen, A. E. C. A. B., et al.
Publicado: (2017)

High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury
por: Sikma, M. A., et al.
Publicado: (2017)

Ontogeny of midazolam glucuronidation in preterm infants
por: de Wildt, Saskia N., et al.
Publicado: (2009)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants
por: Krekels, Elke H. J., et al.
Publicado: (2015)

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
por: Oosten, Astrid W., et al.
Publicado: (2016)

Population pharmacokinetics of haloperidol in terminally ill adult patients
por: Franken, L. G., et al.
Publicado: (2017)

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
por: Abdulla, Alan, et al.
Publicado: (2020)

Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals
por: Atiq, Ferdows, et al.
Publicado: (2018)

Pancytopenia due to proguanil toxicity in a returning traveller with fever
por: Jolink, Hetty, et al.
Publicado: (2010)

Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers
por: Otto, M. E., et al.
Publicado: (2021)

In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates
por: Preijers, Tim, et al.
Publicado: (2021)

Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies
por: Reijers, Joannes A. A., et al.
Publicado: (2016)

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib
por: Atiq, Ferdows, et al.
Publicado: (2016)

The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers
por: El Messaoudi, S., et al.
Publicado: (2016)

Identifying patients with metformin associated lactic acidosis in the emergency department
por: van Berlo-van de Laar, I. R. F., et al.
Publicado: (2020)

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
por: Flint, Robert B., et al.
Publicado: (2018)

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
por: Maring, Jan Gerard, et al.
Publicado: (2010)

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)

Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
por: Shi, Hui-Yan, et al.
Publicado: (2010)

Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers
por: Navaratnam, Visweswaran, et al.
Publicado: (2009)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
por: Ashley, Elizabeth A., et al.
Publicado: (2010)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers
por: Tanaka, Jun, et al.
Publicado: (2012)

VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation
por: Marinova, Milka, et al.
Publicado: (2012)

Pharmacokinetics and pharmacodynamics of moist inhalation epinephrine using a mobile inhaler
por: Breuer, C., et al.
Publicado: (2013)

Importance of hematocrit for a tacrolimus target concentration strategy
por: Størset, Elisabet, et al.
Publicado: (2013)

Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
por: Worboys, Philip D., et al.
Publicado: (2015)

Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines
por: Yu, Yang, et al.
Publicado: (2015)

A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells—using rifampicin as an example
por: Clewe, Oskar, et al.
Publicado: (2015)

Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
por: Small, David S., et al.
Publicado: (2016)

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults
por: Webb, Nicholas J. A., et al.
Publicado: (2016)

Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans
por: Yataba, Ikuko, et al.
Publicado: (2015)

Hair analysis for detection of triptans occasionally used or overused by migraine patients—a pilot study
por: Ferrari, Anna, et al.
Publicado: (2016)

Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs
por: Koya, Yohei, et al.
Publicado: (2016)

Monitoring of adherence to headache treatments by means of hair analysis
por: Ferrari, Anna, et al.
Publicado: (2016)

Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials
por: Dymond, Angela W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gfv05hecld6pp7ur6nuvpaqom6